Your argument is sound. It is however, built on one glaring assumption: the people in charge of the publicly funded healthcare systems are primarily incentivized to find cheap and safe treatments for the illness.
I think when you look at the selective medicare payments, the ventilator contracts, and the price of the 'recommended' patent-drugs like Remdisivir... it quickly becomes apparent that our public incentive structure is profoundly broken.